WhiteOak Capital Pharma and Healthcare Fund holds 61 instruments (93.64% equity), led by Divi's Laboratories Limited (8.45%), Sun Pharmaceutical Industries Limited (7.4%) and Torrent Pharmaceuticals Limited (6.78%), as of its 31 August 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of WhiteOak Capital Pharma and Healthcare Fund, managed by WhiteOak Capital Mutual Fund, based on its monthly portfolio disclosure dated 31 August 2026. The fund holds 61 instruments with an equity allocation of 93.64%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
WhiteOak Capital Pharma and Healthcare Fund's top 10 holdings account for 46.3% of its portfolio, more diversified than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 88.27% of net assets, spread across 3 sectors in total. Since its 31 July 2026 disclosure, the fund added 2 new positions and exited 1 position, with Divi's Laboratories Limited seeing the largest move (+4.59pp to 8.45%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Divi's Laboratories Limited | 3.86% → 8.45% | ▲ +4.59 |
| IPCA Laboratories Limited | 1.12% → 2.66% | ▲ +1.54 |
| Global Health Limited | 1.18% → 1.92% | ▲ +0.74 |
| Shaily Engineering Plastics Limited | 1.39% → 2.01% | ▲ +0.62 |
| Aarti Pharmalabs Limited | 0.85% → 1.1% | ▲ +0.25 |
| Anthem Biosciences Limited | 1.47% → 1.68% | ▲ +0.21 |
| MANIPAL HEALTH ENTERPRISES L | 0.97% → 1.15% | ▲ +0.18 |
| Sai Life Sciences Limited | 3.18% → 3.32% | ▲ +0.14 |
| Orchid Pharma Limited | 0.27% → 0.41% | ▲ +0.14 |
| Thyrocare Technologies Limited | 2.2% → 2.31% | ▲ +0.11 |
| Stock | Weight | Change |
|---|---|---|
| Laurus Labs Limited | 4.94% → 3.78% | ▼ -1.16 |
| Sun Pharmaceutical Industries Limited | 8.53% → 7.4% | ▼ -1.13 |
| Torrent Pharmaceuticals Limited | 7.81% → 6.78% | ▼ -1.03 |
| Max Healthcare Institute Limited | 3.76% → 3.05% | ▼ -0.71 |
| Fortis Healthcare Limited | 2.2% → 1.65% | ▼ -0.55 |
| Aether Industries Limited | 1.47% → 0.97% | ▼ -0.5 |
| Innova Captab Limited | 1.1% → 0.61% | ▼ -0.49 |
| Cipla Limited | 3.72% → 3.25% | ▼ -0.47 |
| Procter & Gamble Health Limited | 1.7% → 1.25% | ▼ -0.45 |
| Krishna Institute of Medical Sciences Limited | 2.34% → 1.92% | ▼ -0.42 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Mar – Aug 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: WhiteOak Capital Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 August 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.